5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

IOL Chemicals And Pharmaceuticals Ltd.

•
iolcp.comBSE: 524164NSE: IOLCP
Market Cap₹ 5,680 Cr.
Current Price
High / Low₹ 219 / 67
Stock P/E33.8
Book Value₹ 63
Price to Book1.19
Dividend Yield0.10 %
ROCE10.7 %
ROE7.9 %
Face Value₹ 2

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Pharmaceutical: 60.2% • Chemical: 39.8%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 89.8% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.83x)
  • Company comfortably covers its interest (13.7x coverage)
  • Company generates healthy free cash flow

CONS

  • Company has a low return on equity of 7.5% over last 3 years
  • Company has a low return on capital employed of 10.6%
  • Valuation is stretched - P/E of 33.8 is well above its own 5-year median (15.5)
  • Though reporting repeated profits, the company pays out little dividend (4.3%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.IOLCP193.5033.795679.760.1064.4089.80756.2637.0810.6513.68
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
563545520504502526523528552568580619756
491481476454451484476465490510523527678
Operating Profit73644450514247636257579279
OPM %12.88%11.77%8.52%9.83%10.17%7.91%8.96%11.89%11.26%10.06%9.87%14.93%10.38%
7788764577-628
Interest4443244443434
Depreciation14161616171819192020202021
Profit before Tax61513237402628454640287187
Tax %25.04%26.01%28.08%25.75%24.16%26.18%26.15%29.71%25.44%25.98%25.30%24.93%25.71%
Net Profit0000301921313430215364
7.816.453.930.941.020.650.701.071.161.020.701.812.19

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
2,1842,2172,1332,0792,3192,524
1,9261,9911,9021,8772,0502,238
Operating Profit258226231202269285
OPM %11.83%10.18%10.81%9.73%11.60%11.31%
182630221011
Interest81616151514
Depreciation434663728082
Profit before Tax225189182138184226
Tax %25.43%26.24%26.00%26.74%25.34%25.46%
Net Profit168139134101138168
EPS28.5623.7022.903.444.69—
Dividend Payout %14.01%16.88%21.84%23.24%4.27%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
2%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
0%

STOCK PRICE CAGR

10 Years:
21%
5 Years:
12%
3 Years:
30%
1 Year:
75%

RETURN ON EQUITY

10 Years:
—
5 Years:
9%
3 Years:
8%
Last Year:
8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Feb 17

₹ 0.50

Rs.1.0000 per share(50%)Interim Dividend

2025

Feb 18

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2024

Feb 16

₹ 0.50

Rs.5.0000 per share(50%)Interim Dividend

2023

Feb 17

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2022

Feb 15

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

2021

Sep 8

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2020

Nov 17

₹ 0.40

Rs.4.0000 per share(40%)Interim Dividend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital5959595959
1,3341,4491,5531,6291,740
438033117134
Trade Payables409314469428483
179167168178215
Total Liabilities2,0242,0682,2822,4112,630
5617529331,1711,182
Capital Work in Progress102811002194
220202121
410326425361371
00471514603
Cash & Bank14022143208198
809868189116162
Total Assets2,0242,0682,2822,4112,630

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
156169290179214
Cash from Investing-121-120-191-154-198
Cash from Financing-2-4-9246-29
-29-2670-13

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
48.1952.6252.6252.6252.6252.6257.4862.28
1.631.491.472.592.252.081.724.87
0.070.070.070.020.040.020.020.43
Government0.000.000.000.000.000.000.000.00
50.1145.8245.8444.7745.0945.2840.7832.42

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-11 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording

2026-09-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-09-09
General Updates

2026-09-09 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates

2026-09-02
Shareholders meeting

2026-09-02 - Submission of Voting Results along with Scrutinizer s Report with regard to the 39th Annual General Meeting of the Company

2026-09-02
Shareholders meeting

2026-09-02 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 02, 2026

2026-08-26
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-26 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

2026-08-20
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Transcript

2026-08-18
Copy of Newspaper Publication

2026-08-18 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording

News

Recent coverage and analyst commentary for IOLCP

Loading news…

🤖

AI Stock Analyst

IOL Chemicals And Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login